RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility
about
Extracting Diffusive States of Rho GTPase in Live Cells: Towards In Vivo BiochemistryMyopodin isoforms alter the chemokinetic response of PC3 cells in response to different migration stimuli via differential effects on Rho-ROCK signaling pathwaysRhoC Promotes Metastasis via Activation of the Pyk2 Pathway in Prostate CancerA novel microtubule de-stabilizing complementarity-determining region C36L1 peptide displays antitumor activity against melanoma in vitro and in vivoStriking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progressionExpression of G3BP and RhoC in esophageal squamous carcinoma and their effect on prognosis.Increased potency of the PHSCN dendrimer as an inhibitor of human prostate cancer cell invasion, extravasation, and lung colony formationStatins and prostate cancer: role of cholesterol inhibition vs. prevention of small GTP-binding proteinsSelective amino acid restriction differentially affects the motility and directionality of DU145 and PC3 prostate cancer cells.Type I collagen receptor (alpha2beta1) signaling promotes prostate cancer invasion through RhoC GTPaseMicroRNA-372 inhibits endometrial carcinoma development by targeting the expression of the Ras homolog gene family member C (RhoC).alpha(5)beta(1) Integrin Ligand PHSRN Induces Invasion and alpha(5) mRNA in Endothelial Cells to Stimulate AngiogenesisRhoGDIα-dependent balance between RhoA and RhoC is a key regulator of cancer cell tumorigenesis.RhoC and guanine nucleotide exchange factor Net1 in androgen-unresponsive mouse mammary carcinoma SC-4 cells and human prostate cancer after short-term endocrine therapy.The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasion.Caveolin-1 mediates inflammatory breast cancer cell invasion via the Akt1 pathway and RhoC GTPase.Down regulation of RhoC by microRNA-138 results in de-activation of FAK, Src and Erk1/2 signaling pathway in head and neck squamous cell carcinoma.Optimization of novel nipecotic bis(amide) inhibitors of the Rho/MKL1/SRF transcriptional pathway as potential anti-metastasis agents.HBx and HBs regulate RhoC expression by upregulating transcription factor Ets-1.Farnesyl transferase inhibitor treatment of breast cancer cells leads to altered RhoA and RhoC GTPase activity and induces a dormant phenotype.RhoC GTPase activation assay.Interaction of Pyk2 and PTP-PEST with leupaxin in prostate cancer cells.A role for the G12 family of heterotrimeric G proteins in prostate cancer invasion.Small-Molecule Inhibition of Rho/MKL/SRF Transcription in Prostate Cancer Cells: Modulation of Cell Cycle, ER Stress, and Metastasis Gene Networks.Role of the lncRNA ABHD11-AS1 in the tumorigenesis and progression of epithelial ovarian cancer through targeted regulation of RhoC.Individual rac GTPases mediate aspects of prostate cancer cell and bone marrow endothelial cell interactions.RhoA and RhoC -siRNA inhibit the proliferation and invasiveness activity of human gastric carcinoma by Rho/PI3K/Akt pathwayTargeting RhoC by Way of Ribozyme Trangene in Human Breast Cancer Cells and its Impact on Cancer Invasion.RhoC
P2860
Q28550544-74155781-7A9E-486E-ACAB-FFD7CB844D6BQ28910358-9F20EF03-6589-44C1-BB5C-1EFF4DE661A8Q29012761-0C90103C-A7A3-4237-A935-F7A8364DDAE3Q30665888-8389B4C0-3A49-4CBB-8E36-CC6379E57B77Q33965278-F579F98C-371E-4CFB-9966-C43EDF0670D3Q34382148-CF38413B-AD36-4B1C-B879-EAFF7B0ECDBAQ34649015-308D1394-2119-496C-B606-10D0C77CDAA2Q35264079-346F9FF5-5D23-4B8B-AE84-86E455133D9EQ36106835-32C968A9-2CE4-4DAF-B296-72E3EA1EBB61Q36787638-33D2BDA0-8F0D-4F48-BC07-42313E13C89EQ36916304-8DA5E465-2CE8-4A19-A545-3A593E940F1DQ37109451-3207728B-FA79-48CB-B374-64DE78D29F49Q38274663-1103840D-1C64-45A7-92A4-F45CEED2574AQ38330186-DBE14817-12B5-4152-B7C9-7330232CEF07Q38858833-D3324F9B-BBCA-42F6-857F-82358DEC2C1AQ38923177-141491FA-D916-4C4F-AEC1-0A96BB50528EQ39021212-6CB72CFC-38F5-4004-AAB1-86096D8F4A52Q39147635-726499D7-650E-47BD-A679-7492CA5FF683Q39182979-43B6BA70-66B1-4628-9D08-6CB89E4BF7C9Q39658220-D1395670-BA01-4161-B319-A2AF2AA48CCAQ39660733-78F1F0D6-9D1E-40CD-86A8-23C7FA5B99A3Q40165268-696C437C-0897-494D-BED4-DA58FF2D3234Q40264901-4A982398-0ED6-42DB-87E1-462BF2AB38F5Q40967702-C5B7AEFB-5457-4331-B0CF-CFD562F384D5Q41451334-4734A003-38C0-40AD-BD3B-41929FC2E423Q41926923-9E1B23DD-7A37-4236-8E37-1C48A9F5CABCQ41967598-499AA8CA-EFB4-42DB-8D25-E441D061322CQ47102665-35A3C8AA-3290-4ED1-B6D3-D5071EB2AB13Q56592930-17476553-6E61-4DA0-9045-15F5D12DA26F
P2860
RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility
@ast
RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility
@en
RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility
@nl
type
label
RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility
@ast
RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility
@en
RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility
@nl
prefLabel
RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility
@ast
RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility
@en
RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility
@nl
P2093
P3181
P356
P1433
P1476
RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility
@en
P2093
C M van Golen
E J Dashner
K L van Golen
P2888
P304
P3181
P356
10.1038/SJ.ONC.1209260
P407
P577
2006-04-13T00:00:00Z
P5875
P6179
1042338625